Newswise — John T. Hunt, Ph.D., executive director of oncology drug discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, N.J., has been voted Chairperson-elect of the Chemistry in Cancer Research Working Group of the American Association for Cancer Research (CICR/AACR). He will accede to the office of chairperson in April 2007 at the 98th Annual Meeting in Los Angeles, Calif.
The goal of CICR/AACR is to bring together distinguished chemists in cancer research and other cancer scientists in chemistry-related fields for ongoing discussion of the present status and future promise of this important discipline.
"I will work to further advance Working Group initiatives to increase the visibility and impact of chemists within AACR by broadening the membership of the Working Group and increasing involvement by young researchers," said Hunt.
CICR/AACR began as a task force in 1999 and became a working group open for membership in 2006. There are currently more than 300 members. This was the inaugural election; previous chairs were appointed by AACR leadership.
Hunt, a founding member of CICR/AACR, currently serves on the editorial advisory board of the Journal of Medicinal Chemistry. He is the 2002 recipient of the Bristol-Myers Squibb Ondetti and Cushman Innovation Award.
For more information on CICR/AACR please visit: http://www.aacr.org/Default.aspx?p=6655
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 24,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 60 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts over 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.
RSS